Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Danaher Corp DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.


NYSE:DHR - Post by User

<< Previous
Bullboard Posts
Post by edwardebreen15on Aug 23, 2022 1:00am
271 Views
Post# 34913240

Downstream Processing Market Size, Growth & Scope 2021-26

Downstream Processing Market Size, Growth & Scope 2021-26

According to IMARC Group’s latest report, titled Downstream Processing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market is expected to grow at a CAGR of around 14% during 2021-2026. Downstream processing (DSP) refers to a set of operations required for recovering and purifying biosynthetic components extracted from various natural sources, including cells, cultured fluids, and plant or animal tissues. It involves flocculation, centrifugation, flotation, and filtration as commonly deployed techniques that are performed after solid-liquid separation, concentration, and chromatography purification processes. These methods assist in maximizing product recovery and minimizing overall production cost, due to which it is extensively used for formulating vaccines, antibiotics, antibodies, and human growth hormones. 

 

Request for a PDF sample of this report: https://www.imarcgroup.com/downstream-processing-market/requestsample

 

The rising demand for manufacturing of effective vaccines on account of the increasing prevalence of various infectious diseases and the outbreak of coronavirus disease (COVID-19) pandemic across the globe is primarily driving the downstream processing market growth. In line with this, significant advancements in bioprocessing technologies have led to the widespread adoption of continuous downstream processing systems for performing multi-component separations, which, in turn, is propelling market growth. Apart from this, strategic collaborations amongst contract manufacturing organizations (CMOs) and pharmaceutical manufacturers for optimizing downstream purification processes at reduced capital investments and procedure costs are creating a positive outlook for the market. Looking forward, IMARC Group expects the global downstream processing market to continue its robust growth during the forecast period (2021-2026).

 

Checkout Now: https://www.imarcgroup.com/checkout?id=3718&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • 3M Company
  • Boehringer Ingelheim International GmbH
  • Corning Corporation
  • Danaher Corporation
  • Eppendorf AG
  • Lonza Group AG
  • Merck KGaA
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

Market Segmentation:

 

Breakup by Technique:

  • Solid-Liquid Separation
  • Cell Disruption
  • Concentration
  • Purification by Chromatography
  • Formulation

Breakup by Product:

  • Chromatography Systems
  • Filters
  • Evaporators
  • Centrifuges
  • Dryers
  • Others

Breakup by Application:

  • Antibiotic Production
  • Hormone Production
  • Antibodies Production
  • Enzyme Production
  • Vaccine Production
  • Others

Breakup by End Use:

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figureshttps://www.imarcgroup.com/downstream-processing-market

 

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

 

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

East Africa Generic Drug Market: https://www.imarcgroup.com/east-africa-generic-drug-market

Europe Generic Drug Market: https://www.imarcgroup.com/europe-generic-drug-market

India Minimally Invasive Surgery Market: https://www.imarcgroup.com/india-minimally-invasive-surgery-market

Europe Transfection Technologies Market: https://www.imarcgroup.com/europe-transfection-technologies-market

Vein Illumination Devices Market: https://www.imarcgroup.com/vein-illumination-devices-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts